Market Cap 437.62M
Revenue (ttm) 0.00
Net Income (ttm) -124.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 627,000
Avg Vol 1,017,716
Day's Range N/A - N/A
Shares Out 77.87M
Stochastic %K 13%
Beta 2.53
Analysts Strong Sell
Price Target $15.58

Company Profile

Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, which is in phase 1/2 for the treatment of Duchenne muscular dystrophy. It also develops SGT-212 for the treatment of Friedreich's ataxia that is in phase 1b clinical trial; SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia that is in preclinical phase; SGT-601 the treatment of TNNT2-mediated dilated cardiomyopath...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 337 4680
Address:
500 Rutherford Avenue, Third Floor, Charlestown, United States
MobyDick2324
MobyDick2324 Oct. 27 at 7:47 PM
$SLDB @pharmd2828 Are you referring to following Catalysts?? Specially SGT-003? - Duchenne (SGT-003): 15 participants dosed in the Phase 1/2 INSPIRE DUCHENNE trial and dosing remains ongoing; On track to discuss regulatory pathways with U.S. FDA in Q4 2025 - - FA (SGT-212): Phase 1b trial initiation expected in Q4 2025 - - CPVT (SGT-501): Phase 1b trial initiation expected in Q4 2025 - - Capsids (AAV-SLB101): Over 25 agreements or licenses with academic labs, institutions and corporations for the use of AAV-SLB101 have been executed -
0 · Reply
aletz
aletz Oct. 26 at 9:46 PM
$SLDB https://www.biostockinfo.com/slda/ My DD on SLDB, I really like this stock $DYN $RNA
0 · Reply
pharmd2828
pharmd2828 Oct. 26 at 2:25 AM
$SLDB short interest went down by 1.5 m shares in the first 2 weeks of October! Short covering & going long possibly before binary events in Q4! I’m long SLDB
0 · Reply
vjtweet
vjtweet Oct. 20 at 8:03 PM
$SLDB jumped the gun and bought today. To add more in Buy Zone.
2 · Reply
type12
type12 Oct. 17 at 11:40 PM
0 · Reply
Bio_Invest101
Bio_Invest101 Oct. 10 at 3:25 PM
$SLDB Latest SI is second highest
0 · Reply
Bangra
Bangra Oct. 8 at 4:31 PM
$SLDB I can't wait to hear about FDA approval.
1 · Reply
DrRivington
DrRivington Oct. 8 at 4:25 PM
$SLDB when she runs, she runs!!
0 · Reply
JazzyJ03
JazzyJ03 Oct. 8 at 4:05 PM
$SLDB helloooo!
0 · Reply
Trident1014
Trident1014 Oct. 8 at 3:07 PM
$SLDB Just keep adding the dips. Waiting for $15
1 · Reply
Latest News on SLDB
Solid Biosciences to Present at Upcoming Scientific Meetings

Oct 1, 2025, 8:00 AM EDT - 26 days ago

Solid Biosciences to Present at Upcoming Scientific Meetings


Solid Biosciences Announces Pricing of Underwritten Offering

Feb 18, 2025, 7:00 AM EST - 8 months ago

Solid Biosciences Announces Pricing of Underwritten Offering


Solid Biosciences Added to the Nasdaq Biotechnology Index

Dec 23, 2024, 4:05 PM EST - 11 months ago

Solid Biosciences Added to the Nasdaq Biotechnology Index


Buy Solid Biosciences: Unpacking Its Main Value Driver

Apr 10, 2024, 7:32 PM EDT - 1 year ago

Buy Solid Biosciences: Unpacking Its Main Value Driver


Solid Biosciences Announces $109 Million Private Placement

Jan 8, 2024, 7:09 AM EST - 1 year ago

Solid Biosciences Announces $109 Million Private Placement


MobyDick2324
MobyDick2324 Oct. 27 at 7:47 PM
$SLDB @pharmd2828 Are you referring to following Catalysts?? Specially SGT-003? - Duchenne (SGT-003): 15 participants dosed in the Phase 1/2 INSPIRE DUCHENNE trial and dosing remains ongoing; On track to discuss regulatory pathways with U.S. FDA in Q4 2025 - - FA (SGT-212): Phase 1b trial initiation expected in Q4 2025 - - CPVT (SGT-501): Phase 1b trial initiation expected in Q4 2025 - - Capsids (AAV-SLB101): Over 25 agreements or licenses with academic labs, institutions and corporations for the use of AAV-SLB101 have been executed -
0 · Reply
aletz
aletz Oct. 26 at 9:46 PM
$SLDB https://www.biostockinfo.com/slda/ My DD on SLDB, I really like this stock $DYN $RNA
0 · Reply
pharmd2828
pharmd2828 Oct. 26 at 2:25 AM
$SLDB short interest went down by 1.5 m shares in the first 2 weeks of October! Short covering & going long possibly before binary events in Q4! I’m long SLDB
0 · Reply
vjtweet
vjtweet Oct. 20 at 8:03 PM
$SLDB jumped the gun and bought today. To add more in Buy Zone.
2 · Reply
type12
type12 Oct. 17 at 11:40 PM
0 · Reply
Bio_Invest101
Bio_Invest101 Oct. 10 at 3:25 PM
$SLDB Latest SI is second highest
0 · Reply
Bangra
Bangra Oct. 8 at 4:31 PM
$SLDB I can't wait to hear about FDA approval.
1 · Reply
DrRivington
DrRivington Oct. 8 at 4:25 PM
$SLDB when she runs, she runs!!
0 · Reply
JazzyJ03
JazzyJ03 Oct. 8 at 4:05 PM
$SLDB helloooo!
0 · Reply
Trident1014
Trident1014 Oct. 8 at 3:07 PM
$SLDB Just keep adding the dips. Waiting for $15
1 · Reply
Impatient_Investor
Impatient_Investor Oct. 7 at 3:34 PM
$SLDB pump and dump garbage
0 · Reply
Stockboi_
Stockboi_ Oct. 2 at 9:37 PM
$SLDB flag broken for me. Stopping out here. Have fun yall
0 · Reply
diggs24
diggs24 Oct. 1 at 8:03 PM
$SLDB Almost like clockwork there's a big push upwards towards the closing bell. It's as if someone(s) are trying to ensure they are holding a heavy position in this overnight. Anyone else seeing this?
1 · Reply
Stockboi_
Stockboi_ Oct. 1 at 5:50 PM
$SLDB as long as the flag don’t break we litttt
0 · Reply
pharmd2828
pharmd2828 Oct. 1 at 2:02 PM
$SLDB https://finance.yahoo.com/news/solid-biosciences-present-upcoming-scientific-120000645.html
0 · Reply
Winning_calls
Winning_calls Sep. 29 at 2:13 PM
$SLDB 😘
0 · Reply
jposmak
jposmak Sep. 29 at 12:21 PM
$SLDB first rule of investment do not believe on internet
0 · Reply
Winning_calls
Winning_calls Sep. 29 at 3:00 AM
$SLDB pick me up @ $6.15
0 · Reply
pharmd2828
pharmd2828 Sep. 28 at 8:05 PM
$SLDB where does SLDB go from here and after great presentation on Friday in Italy ?? Your thoughts? I am long SLDB !!
0 · Reply
pharmd2828
pharmd2828 Sep. 27 at 10:34 PM
$SLDB https://share.google/PdAM61CYOp3vOrXGB
0 · Reply
Doozio
Doozio Sep. 27 at 3:59 PM
$SLDB chop chop huckleberries…. It was always 🐒🍌🧠⏰♾️
0 · Reply